Biogen agreed to give $172.50 per share in cash to Reata, accompanied by term debt issuance. The transaction will close in the fourth quarter of 2023. Biogen’s president and chief executive officer, Christopher Viehbacher, said the company believes it has the foundation in place to...

    Regenerative medicine company, Carmell Therapeutics, announced the execution of a definitive agreement and plan of merger (the “Merger Agreement”) with Flagstaff-based Axolotl Biologix. Axolotl develops, designs, and sells products that are human amnion-based, for...

    Quince Therapeutics (Nasdaq: QNCX) in its agreement to acquire EryDel SpA in a stock-for-stock upfront exchange and potential downstream milestone cash payments. Quince Therapeutics is a biotechnology company focused on acquiring, developing, and commercializing...

Advanco, established as a global pharmaceutical and life sciences track and trace solutions provider, has announced the acquisition of manufacturing automation specialist Vantage Consulting Group. The company will continue to be called advanco, with an enlarged client portfolio of...

TraceLink, a leading digital network platform company enabling end-to-end product orchestration, has announced a partnership with PharmaLink. TraceLink will provide comprehensive DSCSA capabilities for PharmaLink customers, enabling pharmacy dispensers to meet the regulatory...